1. Home
  2. GENE

GENE

Genetic Technologies Ltd ADS

Logo Genetic Technologies Ltd ADS

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 2:13pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

Founded: 1989 Country:
Australia
Australia
Employees: N/A City: N/A
Market Cap: 10.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 28.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.93 EPS Growth: N/A
52 Week Low/High: $1.80 - $5.90 Next Earning Date: 05-13-2024
Revenue: $5,776,090 Revenue Growth: 293.98%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: